Who invested in Replimune Group

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$140Mraised across 1 round since 2024, from 1 source

Latest round: Round, $140MNov 2024
Investors: 6

See who backed them

The rounds

Nov 2024
Round$140M
Source recorded

Founders and team

From Replimune Group's own website: 13 on the team.

Sushil PatelChief Executive Officer
Camilo GarciaChief HR Officer
Emily HillChief Financial Officer
Kostas XynosChief Medical Officer
Michelle DiNapoliChief Commercial Officer
Nina AragamChief Operations Officer
Paul BullockChief Manufacturing Officer
Christy OligerDirector
Dieter WeinandLead Independent Director
Joseph SlatteryDirector
Kapil DhingraDirector
Michael GollerDirector
Philip Astley-SparkeExecutive Chairman

Everyone who backed them

Cormorant Asset ManagementPrivate equity1round

Redmile GroupVC firm1round

Foresite CapitalPrivate equity1round

Omega FundsVC firm1round

Hercules CapitalVenture debt1round

Bain Capital Life SciencesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Replimune Group

Who invested in Replimune Group?

Replimune Group's investors include Cormorant Asset Management, Redmile Group, Foresite Capital, Omega Funds and Hercules Capital, and 1 more on record.